Paragon 28, Inc. (NYSE: FNA) (“Paragon 28” or “P28”), a leading medical device company exclusively focused on the foot and ankle orthopedic market, today announced a range of its preliminary unaudited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback